Neuromonics Names Prominent Audiologists to Help Launch of Cloud-Based OasisPro Share Article

 

Barreneche, Jenkins provide training and guidance of treatment for those suffering from ringing in ears

WESTMINSTER, COLO. (PRWEB) SEPTEMBER 18, 2018

Neuromonics, Inc. is engaging Diana Barreneche, Au.D., and Barbara Jenkins, Au.D., to help train clinicians on the cloud-based version of the Neuromonics Tinnitus Treatment (NTT), the OasisPro.

Both audiologists are nationally and internationally known for their experience in tinnitus treatments, according to Eula Adams, CEO of Neuromonics. “Dr. Jenkins and Dr. Barreneche will bring their experience and knowledge into the Neuromonics Oasis protocol, affording patients a better chance at tinnitus relief and remediation,” he said. “We’re excited to have them on board.”

Only trained and approved audiologists will be authorized to fit the new OasisPro, which deploys the NTT on a patient’s iPad or iPhone. Barreneche and Jenkins will provide full clinical support to audiologists in fitting their tinnitus patients to ensure a successful outcome with the NTT. The clinically and research-proven NTT has an 83 percent success rate for those suffering from ringing in the ears.

Barreneche, who also holds a Certificate of Clinical Competency in Audiology from the American Speech-Language-Hearing Association (ASHA) and is an ASHA fellow, is an audiologist and lecturer with Cognitive Hearing Sciences in Boca Raton, Florida. One of the first doctors trained in the Neuromonics Tinnitus Treatment, her grant-based research has focused on tinnitus diagnosis and sound therapy treatments, including the NTT.

Jenkins, who is Board Certified in Audiology (American Board of Audiology), is Colorado’s first board-certified Doctor of Audiology. She has more than 25 years of hospital and clinical experience in the evaluation and treatment of tinnitus, is a fellow of the Tinnitus Practitioner’s Association and a contributing editor to Hearing Health Magazine. Jenkins is an adjunct professor at Rocky Vista University College of Osteopathic Medicine (Parker, Colorado), where she trains future physicians on the importance of hearing and tinnitus care.

“I am excited to see the advances in the delivery model of the Neuromonics treatment, and to be part of the OasisPro launch and training efforts” said Barreneche. “I was a tinnitus sufferer myself, and my life improved dramatically using NTT. Since then, I have treated many patients successfully with NTT. I am looking forward to help clinicians bring the successful NTT, via the OasisPro, to their patients and to help improve their patients’ daily quality of life.”

Neuromonics, Inc. (http://www.neuromonics.com)
Based in Westminster, Colo., Neuromonics, Inc., manufactures and distributes clinically proven medical devices to treat tinnitus. The patented and clinically proven Neuromonics Oasis™ provides long-term treatment and significant relief for those with severe tinnitus.

With research and development beginning in the early 1990s, Neuromonics has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus. Today, Neuromonics provides its devices to nearly 2,000 hearing professionals on four continents, through direct relationships and reseller partners. Neuromonics has been featured in the national media, including segments on “The Doctors” and CNN.
(end)